Literature DB >> 29399185

IL-8 is upregulated in cervical cancer tissues and is associated with the proliferation and migration of HeLa cervical cancer cells.

Linlin Jia1, Fengying Li2, Mingliang Shao3, Wei Zhang3, Chunbin Zhang1, Xiaolian Zhao1, Haiyan Luan1, Yaling Qi1, Pengxia Zhang1, Lichun Liang1, Xiuyue Jia1, Kun Zhang1, Yan Lu1, Zhe Yang1, Xiulin Zhu1, Qi Zhang1, Jiwei Du4, Weiqun Wang1.   

Abstract

Interleukin-8 (IL-8) serves an important function in chronic inflammation and cancer development; however, the underlying molecular mechanism(s) of IL-8 in uterine cervical cancer remains unclear. The present study investigated whether IL-8 and its receptors [IL-8 receptor (IL-8R)A and IL-8RB] contributed to the proliferative and migratory abilities of HeLa cervical cancer cells, and also investigated the potential underlying molecular mechanisms. Results demonstrated that IL-8 and its receptors were detected in HeLa cells, and levels of IL-8RA were significantly increased compared with those of IL-8RB. Furthermore, the level of IL-8 in cervical cancer tissues was significantly increased compared with that in normal uterine cervical tissues, and migratory and proliferative efficiencies of HeLa cells treated with exogenous IL-8 were increased, compared with untreated HeLa cells. In addition, exogenous IL-8 was able to downregulate endocytic adaptor protein (NUMB), and upregulate IL-8RA, IL-8RB and extracellular signal-regulated protein kinases (ERKs) expression levels in HeLa cells. Results suggest that IL-8 and its receptors were associated with the tumorigenesis of uterine cervical cancer, and exogenous IL-8 promotes the carcinogenic potential of HeLa cells by increasing the expression levels of IL-8RA, IL-8RB and ERK, and decreasing the expression level of NUMB.

Entities:  

Keywords:  endocytic adaptor protein; extracellular-signal-regulated kinase; interleukin-8; interleukin-8 receptor; uterine cervical cancer

Year:  2017        PMID: 29399185      PMCID: PMC5772749          DOI: 10.3892/ol.2017.7391

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  37 in total

1.  MicroRNA-21 promotes the proliferation and inhibits apoptosis in Eca109 via activating ERK1/2/MAPK pathway.

Authors:  Fengxia Liu; Shutao Zheng; Tao Liu; Qing Liu; Meng Liang; Xiuling Li; Ilyar Sheyhidin; Xiaomei Lu; Wenya Liu
Journal:  Mol Cell Biochem       Date:  2013-05-25       Impact factor: 3.396

Review 2.  The role of interleukin-8 and its receptors in gliomagenesis and tumoral angiogenesis.

Authors:  Daniel J Brat; Anita C Bellail; Erwin G Van Meir
Journal:  Neuro Oncol       Date:  2005-04       Impact factor: 12.300

3.  IL-8 signaling plays a critical role in the epithelial-mesenchymal transition of human carcinoma cells.

Authors:  Romaine I Fernando; Marianne D Castillo; Mary Litzinger; Duane H Hamilton; Claudia Palena
Journal:  Cancer Res       Date:  2011-06-08       Impact factor: 12.701

4.  Nonapical and cytoplasmic expression of interleukin-8, CXCR1, and CXCR2 correlates with cell proliferation and microvessel density in prostate cancer.

Authors:  Catherine Murphy; Maryalice McGurk; Johanna Pettigrew; Alfredo Santinelli; Roberta Mazzucchelli; Patrick G Johnston; Rodolfo Montironi; David J J Waugh
Journal:  Clin Cancer Res       Date:  2005-06-01       Impact factor: 12.531

5.  Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012.

Authors:  J Ferlay; E Steliarova-Foucher; J Lortet-Tieulent; S Rosso; J W W Coebergh; H Comber; D Forman; F Bray
Journal:  Eur J Cancer       Date:  2013-02-26       Impact factor: 9.162

6.  Influence of interleukin-8 (IL-8) and IL-8 receptors on the migration of human keratinocytes, the role of PLC-γ and potential clinical implications.

Authors:  Wen G Jiang; Andrew J Sanders; Fiona Ruge; Keith G Harding
Journal:  Exp Ther Med       Date:  2011-12-01       Impact factor: 2.447

7.  Thromboxane A2 Regulates CXCL1 and CXCL8 Chemokine Expression in the Nasal Mucosa-Derived Fibroblasts of Chronic Rhinosinusitis Patients.

Authors:  Yih-Jeng Tsai; Sheng-Po Hao; Chih-Li Chen; Wen-Bin Wu
Journal:  PLoS One       Date:  2016-06-28       Impact factor: 3.240

Review 8.  Recent advances reveal IL-8 signaling as a potential key to targeting breast cancer stem cells.

Authors:  Jagdeep K Singh; Bruno M Simões; Sacha J Howell; Gillian Farnie; Robert B Clarke
Journal:  Breast Cancer Res       Date:  2013       Impact factor: 6.466

9.  The role of interleukin-8 (IL-8) and IL-8 receptors in platinum response in high grade serous ovarian carcinoma.

Authors:  Euan A Stronach; Paula Cunnea; Christina Turner; Tankut Guney; Radhika Aiyappa; Senthuran Jeyapalan; Camila H de Sousa; Alacoque Browne; Nesreen Magdy; James B Studd; Ruethairat Sriraksa; Hani Gabra; Mona El-Bahrawy
Journal:  Oncotarget       Date:  2015-10-13

10.  The Numb/p53 circuitry couples replicative self-renewal and tumor suppression in mammary epithelial cells.

Authors:  Daniela Tosoni; Silvia Zecchini; Marco Coazzoli; Ivan Colaluca; Giovanni Mazzarol; Alicia Rubio; Michele Caccia; Emanuele Villa; Olav Zilian; Pier Paolo Di Fiore; Salvatore Pece
Journal:  J Cell Biol       Date:  2015-11-23       Impact factor: 10.539

View more
  10 in total

1.  Severe cervical inflammation and high-grade squamous intraepithelial lesions: a cross-sectional study.

Authors:  Tengfei Long; Lingli Long; Yaxiao Chen; Yubin Li; Ying Tuo; Yue Hu; Lingling Xie; Gui He; Wen Zhao; Xiaofang Lu; Zhongqiu Lin
Journal:  Arch Gynecol Obstet       Date:  2020-09-26       Impact factor: 2.344

2.  FPR1 mediates the tumorigenicity of human cervical cancer cells.

Authors:  Guangming Cao; Zhenyu Zhang
Journal:  Cancer Manag Res       Date:  2018-11-16       Impact factor: 3.989

3.  Quercetin modulates signaling pathways and induces apoptosis in cervical cancer cells.

Authors:  Madhumitha Kedhari Sundaram; Ritu Raina; Nazia Afroze; Khuloud Bajbouj; Mawieh Hamad; Shafiul Haque; Arif Hussain
Journal:  Biosci Rep       Date:  2019-08-13       Impact factor: 3.840

4.  miR‑302c‑3p and miR‑520a‑3p suppress the proliferation of cervical carcinoma cells by targeting CXCL8.

Authors:  Hong-Mei Ding; Hong Zhang; Juan Wang; Jin-Hua Zhou; Fang-Rong Shen; Ru-Ning Ji; Jia-Yin Shi; You-Guo Chen
Journal:  Mol Med Rep       Date:  2021-03-24       Impact factor: 2.952

5.  Comparison of Cervical Levels of Interleukins-6 and -8 in Patients with and without Cervical Intraepithelial Neoplasia.

Authors:  Zahra Vahedpour; Masoumeh Abedzadeh-Kalahroudi; Mojtaba Sehat; Ahmad Piroozmand; Maedeh Memar
Journal:  Asian Pac J Cancer Prev       Date:  2021-04-01

Review 6.  CXCL8 in Tumor Biology and Its Implications for Clinical Translation.

Authors:  Xingyu Xiong; Xinyang Liao; Shi Qiu; Hang Xu; Shiyu Zhang; Sheng Wang; Jianzhong Ai; Lu Yang
Journal:  Front Mol Biosci       Date:  2022-03-15

7.  Immunometabolic and potential tumor-promoting changes in 3D cervical cell models infected with bacterial vaginosis-associated bacteria.

Authors:  Jason D Maarsingh; Paweł Łaniewski; Melissa M Herbst-Kralovetz
Journal:  Commun Biol       Date:  2022-07-22

Review 8.  RANK-RANKL Signaling in Cancer of the Uterine Cervix: A Review.

Authors:  Peter A van Dam; Yannick Verhoeven; Julie Jacobs; An Wouters; Wiebren Tjalma; Filip Lardon; Tim Van den Wyngaert; Jonatan Dewulf; Evelien Smits; Cécile Colpaert; Hans Prenen; Marc Peeters; Martin Lammens; Xuan Bich Trinh
Journal:  Int J Mol Sci       Date:  2019-05-02       Impact factor: 5.923

9.  Low RECK Expression Is Part of the Cervical Carcinogenesis Mechanisms.

Authors:  Suellen Herbster; Marina Trombetta-Lima; Paulo Thiago de Souza-Santos; Andressa Paladino; Caio Raony Farina Silveira; Mari Cleide Sogayar; Luisa Lina Villa; Ana Paula Lepique; Enrique Boccardo
Journal:  Cancers (Basel)       Date:  2021-05-06       Impact factor: 6.639

10.  Nonphosphorylatable PEA15 mutant inhibits epithelial-mesenchymal transition in triple-negative breast cancer partly through the regulation of IL-8 expression.

Authors:  Jihyun Park; Moises J Tacam; Gaurav Chauhan; Evan N Cohen; Maria Gagliardi; Lakesla R Iles; Naoto T Ueno; Venkata L Battula; Yoo-Kyoung Sohn; Xiaoping Wang; Hak-Sung Kim; Savitri Krishnamurthy; Natalie W Fowlkes; Morgan M Green; Geoffrey A Bartholomeusz; Debu Tripathy; James M Reuben; Chandra Bartholomeusz
Journal:  Breast Cancer Res Treat       Date:  2021-07-09       Impact factor: 4.872

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.